CLASS II ONGOING Device recall · Reported 15 Jan 2025 · FDA Enforcement Report

VivAer Stylus recalled by Aerin Medical

Aerin Medical is recalling Aerin Medical VivAer Stylus, distributed nationwide in the US. The recall was initiated on 12 Nov 2024 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot #10235, exp. 2026-05-01; UDI (01)08886479300269(17)260501(10)10235
Quantity recalled479 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0808-2025
FDA event ID
95832
Recalling firm
Aerin Medical, Sunnyvale, CA
Classification
Class II
Status
Ongoing
Recall initiated
12 Nov 2024
FDA classified
6 Jan 2025
Reported
15 Jan 2025
Type
Voluntary: Firm initiated
Customers notified by
E-Mail
Reason category
Sterility

Timeline

12 Nov 2024Recall initiated by company
6 Jan 2025Classified by FDA+55 days
15 Jan 2025Published in enforcement report+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Some units in a single production lot were programmed incorrectly which will result in the VivAer Stylus being incorrectly recognized as RhinAer Stylus when connected to the Aerin Console.

A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.

Product as listed by the FDA

Aerin Medical VivAer Stylus, REF CAT1785 (individual stylus), and REF CAT500 (5-pack), sterile.

Where it was distributed

US Nationwide Distribution: AL, AZ, CA, CO, GA, ID, IL, IN, KY LA, MI, MN, NY, NE, NY, OH, OR PA, SC, TN, TX, UT, VA, WA, WI, and WV.

Nationwide AlabamaArizonaCaliforniaColoradoGeorgiaIdahoIllinoisIndianaKentuckyLouisianaMichiganMinnesotaNebraskaNew YorkOhioPennsylvaniaSouth CarolinaTennesseeTexasUtah

Questions about this recall

Is VivAer Stylus recalled?

Yes. Aerin Medical recalled VivAer Stylus on 12 Nov 2024. The recall is Class II and its status is Ongoing. Recall number Z-0808-2025.

Why was it recalled?

Some units in a single production lot were programmed incorrectly which will result in the VivAer Stylus being incorrectly recognized as RhinAer Stylus when connected to the Aerin Console.

Which lots are affected?

Lot #10235, exp. 2026-05-01; UDI (01)08886479300269(17)260501(10)10235

Where was it sold?

US Nationwide Distribution: AL, AZ, CA, CO, GA, ID, IL, IN, KY LA, MI, MN, NY, NE, NY, OH, OR PA, SC, TN, TX, UT, VA, WA, WI, and WV.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other Other Medical Devices recalls

All 13,771